Taysha Gene Therapies Inc’s recent filing unveils that its Officer Nagendran Sukumar acquired Company’s shares for reported $1.8 million on Nov 28 ’25. In the deal valued at $4.86 per share,370,172 shares were bought.
Then, Rumana Haque-Ahmed bought 10,770 shares, generating $30,479 in total proceeds.
Before that, Nagendran Sukumar sold 200,000 shares. Taysha Gene Therapies Inc shares valued at $646,000 were divested by the President and Head of R&D at a price of $3.23 per share. As a result of the transaction, Nagendran Sukumar now holds 1,006,439 shares, worth roughly $4.77 million.
Raymond James initiated its Taysha Gene Therapies Inc [TSHA] rating to a Strong buy in a research note published on October 21, 2025; the price target was $13. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. BMO Capital Markets began covering TSHA with “an Outperform” recommendation on June 27, 2024. Piper Sandler started covering the stock on April 09, 2024. It rated TSHA as “an Overweight”.
Price Performance Review of TSHA
On Friday, Taysha Gene Therapies Inc [NASDAQ:TSHA] saw its stock fall -2.47% to $4.74. Over the last five days, the stock has gained 18.80%. Taysha Gene Therapies Inc shares have risen nearly 64.01% since the year began. Nevertheless, the stocks have risen 173.99% over the past one year. While a 52-week high of $5.51 was reached on 10/15/25, a 52-week low of $1.05 was recorded on 04/09/25.
Levels Of Support And Resistance For TSHA Stock
The 24-hour chart illustrates a support level at 4.67, which if violated will result in even more drops to 4.60. On the upside, there is a resistance level at 4.86. A further resistance level may holdings at 4.99.
How much short interest is there in Taysha Gene Therapies Inc?
A steep rise in short interest was recorded in Taysha Gene Therapies Inc stocks on 2025-11-14, growing by 6.11 million shares to a total of 48.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 41.98 million shares. There was a rise of 12.7%, which implies that there is a positive sentiment for the stock.
